Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences
Abstract To evaluate the clinical benefit of new medicines for type 2 diabetes mellitus (T2DM), the Dutch guideline committee T2DM in primary care established the importance of outcomes and minimal clinically important differences (MCIDs). The present study used an online questionnaire to investigat...
Main Authors: | Marloes Dankers, Marjorie H. J. M. G. Nelissen‐Vrancken, Bertien H. Hart, Anke C. Lambooij, Liset vanDijk, Aukje K. Mantel‐Teeuwisse |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.750 |
Similar Items
-
Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements.
by: Marloes Dankers, et al.
Published: (2023-01-01) -
Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease
by: Marloes Dankers, et al.
Published: (2020-02-01) -
Determining minimal important differences for patient-reported outcome measures in shoulder, lateral elbow, patellar and Achilles tendinopathies using distribution-based methods
by: Dimitris Challoumas, et al.
Published: (2023-03-01) -
Establishing the Minimum Clinically Significant Difference (MCID) and the Patient Acceptable Symptom Score (PASS) for the Hospital Anxiety and Depression Scale (HADS) in Patients with Rotator Cuff Disease and Shoulder Prosthesis
by: Umile Giuseppe Longo, et al.
Published: (2023-02-01) -
Using minimal clinically important differences to measure long-term transitions of osteosarcopenia: The New Mexico Aging Process Study
by: Lara Vlietstra, et al.
Published: (2023-03-01)